Novel technique for treatment of chronic venous insufficiency found
Different treatment options are used for the treatment of chronic venous insufficiency (CVI), which impairs the quality of life, especially in later stages. Researchers of Turkey have found a novel modified technique for the treatment of chronic venous insufficiency. They found the combination of percutaneous embolization of SV (Saphenous Vein) with n-butyl cyanoacrylate (NBCA) and high ligation is safe and efficient in CVI. The research details were published in the Indian Journal of Surgery on April 20, 2020.
There are numerous surgical techniques used in the treatment of venous insufficiency. Surgical options are used in the case of failure with conservative treatment and pharmacological methods. Each of these techniques has its advantages and disadvantages. New hybrid methods are being developed to overcome adverse effects and possible complications such as deep vein thrombosis, phlebitis, and infections. With the same idea, the researchers of Bolu Abant Izzet Baysal University Faculty of Medicine conducted a study to evaluate and present a preliminary report on their novel technique ( a combination of percutaneous embolization of SV with n-butyl cyanoacrylate (NBCA) and high ligation).
Researchers included a total of 47 patients, aged between 28 and 62 years diagnosed with chronic venous insufficiency. They evaluated patients with a Comprehensive Classification System and Venous Clinical Severity Score (VCSS) for Chronic Venous Disorders. They recorded patients demographic features such as age and gender, and clinical features such as CEAP classes, VCSSs, and vena saphena magna VSM diameters. All patients were treated with a novel modified hybrid technique including Venablock embolization system and surgical high ligation of the greater SV. Researchers recorded the patient's preprocedural, intraprocedural, and postprocedural period follow-up data and analyzed them retrospectively.
They classified patients according to the CEAP classification, among 47 patients, 38 patients (80.8%) were classified as C3, six patients (12.8%) as C4, and three patients (6.4%) as C2. They found the mean preoperative VCSS of the patients was 8.83 ± 1.31 and the mean postoperative VCSS was 2.85 ± 0.71. They noted the mean postoperative VCSS was statistically significantly lower than the mean preoperative VCSS. They recorded no complications or side effects and the technical success rate was found to be 100%
The authors concluded, "We suggest that this novel method is efficient and safe in the treatment of chronic venous insufficiency because it eliminates the need for general anesthesia with short operation time and adhesion of all branches of the saphenous vein, thus preventing possible complications".
For further information:
https://link.springer.com/article/10.1007/s12262-020-02191-1#citeas
